ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 52 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $22,000 | -33.3% | 10,339 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $33,000 | -15.4% | 10,339 | -30.3% | 0.00% | 0.0% |
| Q4 2016 | $39,000 | -32.8% | 14,839 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $58,000 | +3.6% | 14,839 | -28.8% | 0.00% | -25.0% |
| Q2 2016 | $56,000 | -12.5% | 20,839 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $64,000 | -17.9% | 20,839 | -18.9% | 0.00% | 0.0% |
| Q3 2015 | $78,000 | -28.4% | 25,709 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $109,000 | +10.1% | 25,709 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $99,000 | -42.8% | 25,709 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $173,000 | +22.7% | 25,709 | 0.0% | 0.01% | +50.0% |
| Q3 2014 | $141,000 | -46.6% | 25,709 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $264,000 | -14.6% | 25,709 | 0.0% | 0.01% | -11.1% |
| Q1 2014 | $309,000 | -46.2% | 25,709 | -49.3% | 0.01% | -50.0% |
| Q4 2013 | $574,000 | +68.3% | 50,709 | 0.0% | 0.02% | +63.6% |
| Q3 2013 | $341,000 | -27.4% | 50,709 | 0.0% | 0.01% | -38.9% |
| Q2 2013 | $470,000 | – | 50,709 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |